NCT01225029

Brief Summary

Transient tachypnea of the newborn (TTN) is a diagnosis given to infants born between 34 and 42 weeks gestation who develop difficulty breathing during the first days of life when no specific cause of the breathing difficulty can be identified. Little is known about why some babies develop TTN, and there have not been many formal studies of the best way to take care of babies with this disease. Babies with TTN get better on their own within three to five days after birth, but may require extra oxygen to breath well. Most physicians believe that the symptoms of TTN are related to poor clearance of fluid from the newborn's lungs. Babies with TTN have extra fluid visible on chest x-ray. Diuretics, medicines that can help clear extra lung fluid in adults and in babies with extra lung fluid for other reasons, do not to help babies with TTN. Babies with TTN need intravenous fluids to be healthy because they breathe too fast to be able to eat. Breastfed babies only get a very small amount of fluid in the first few days of life, as it normally takes several days for a new mother to begin producing breastmilk. No one has yet examined whether giving babies with TTN an amount of fluid similar to the small amount they would receive if they could breastfeed would help them recover from TTN faster. In this study, the investigators compare whether giving newborns "standard" intravenous fluid or amounts of intravenous fluid more close to what a breastfed baby would receive speeds recovery in newborns with TTN.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2008

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 20, 2010

Completed
3.1 years until next milestone

Results Posted

Study results publicly available

November 28, 2013

Completed
Last Updated

November 28, 2013

Status Verified

September 1, 2013

Enrollment Period

2.3 years

First QC Date

October 18, 2010

Results QC Date

September 24, 2013

Last Update Submit

September 24, 2013

Conditions

Keywords

premature birthlate preterm birthrespiratory distress of the newbornTransient tachypnea of the newborn

Outcome Measures

Primary Outcomes (1)

  • Duration of Respiratory Support

    every hour until patient stable without respiratory support, an average of approximately 55 hours and a maximum of 205 hours

Secondary Outcomes (2)

  • Duration of ICU Admission

    every day until discharge, an average of approximately 8 days and a maximum of 12 days

  • Time to First Enteral Feed

    hour until first enteral feed achieved, an average of approximately 40 hours and a maximum of 100 hours

Study Arms (2)

Standard Fluids

NO INTERVENTION

Term neonates receive total fluids of 60 mL/kg/day on day of life (DOL) 1. Preterm neonates receive total fluids of 80 mL/kg/day on DOL 1. Each group receives an extra 20 mL/kg/day daily until total fluids of 150 mL/kg/day are achieved.

Restricted Fluids

EXPERIMENTAL

Term neonates receive total fluids of 40 mL/kg/day on day of life (DOL) 1. Preterm neonates receive total fluids of 60 mL/kg/day on DOL 1. Each group receives an extra 20 mL/kg/day daily until total fluids of 150 mL/kg/day are achieved

Other: Amount of total fluids

Interventions

Term neonates receive either total fluids of 60 mL/kg/day (standard) or 40 mL/kg/day (restricted) on day of life (DOL) 1. Preterm neonates receive total fluids of 80 mL/kg/day (standard) or 60 mL/kg/day (restricted) on DOL 1. Each group receives an extra 20 mL/kg/day daily until total fluids of 150 mL/kg/day are achieved.

Restricted Fluids

Eligibility Criteria

AgeUp to 24 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Gestational age at birth 34 and 42 weeks of gestation
  • Admission to the Mount Sinai NICU during the first 24 hours of life
  • Diagnosis during the first 24 hours of life of transient tachypnea of the newborn

You may not qualify if:

  • Gestational age at birth less than 34 weeks or greater than 42 weeks at birth
  • No diagnosis of TTN made in the first 24 hours of life
  • Additional infant diagnosis of major cardiac disease
  • Additional infant diagnosis of major pulmonary disease other than TTN
  • Additional infant diagnosis of meconium aspiration syndrome
  • Additional infant diagnosis of major congenital anomaly with potential to affect respiratory status in the neonatal period
  • Additional infant diagnosis of infectious disease process potentially affecting respiratory status in the neonatal period
  • Observation of thick meconium in the amniotic fluid at delivery.
  • Maternal diagnosis of chorioamnionitis or other infection of the uterus or fallopian tubes pre- or peri-partum.
  • Criteria for removal from the study:
  • (a) Additional infant diagnosis of major cardiac, pulmonary, or other disease process potentially affecting respiratory status in the neonatal period (i.e., infection, meconium aspiration, pneumothorax, congenital anomaly) present during the study period. (b) Positive test of infection (e.g. blood, CSF, or urine culture; viral DFA; microscopy) drawn from infant at any point during the study period. (c) Maternal diagnosis of chorioamnionitis or other infection of the uterus or fallopian tubes at any point during hospital stay. (d) Objective clinical signs of dehydration: (i) Newborn urine output less than 2 mL/kg/hr over a twelve hour period at any point during the study period. (ii) Newborn serum sodium less than 130 mEq/L or greater than 150 mEq/L at any point during the study period. (iii) Newborn weight loss \>10% of birth weight at any point during the study period.
  • (e) Newborn blood glucose by point-of-care testing of less than 40 mg/dL at any point during the study period. (f) Administration of exogenous surfactant at any point during the study period.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai School of Medicine

New York, New York, 10029, United States

Location

Related Publications (12)

  • Avery ME, Gatewood OB, Brumley G. Transient tachypnea of newborn. Possible delayed resorption of fluid at birth. Am J Dis Child. 1966 Apr;111(4):380-5. doi: 10.1001/archpedi.1966.02090070078010. No abstract available.

    PMID: 5906048BACKGROUND
  • Zanardo V, Simbi AK, Franzoi M, Solda G, Salvadori A, Trevisanuto D. Neonatal respiratory morbidity risk and mode of delivery at term: influence of timing of elective caesarean delivery. Acta Paediatr. 2004 May;93(5):643-7. doi: 10.1111/j.1651-2227.2004.tb02990.x.

    PMID: 15174788BACKGROUND
  • Riskin A, Abend-Weinger M, Riskin-Mashiah S, Kugelman A, Bader D. Cesarean section, gestational age, and transient tachypnea of the newborn: timing is the key. Am J Perinatol. 2005 Oct;22(7):377-82. doi: 10.1055/s-2005-872594.

    PMID: 16215925BACKGROUND
  • Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol. 2006 Feb;30(1):34-43. doi: 10.1053/j.semperi.2006.01.006.

    PMID: 16549212BACKGROUND
  • Jain L, Dudell GG. Respiratory transition in infants delivered by cesarean section. Semin Perinatol. 2006 Oct;30(5):296-304. doi: 10.1053/j.semperi.2006.07.011.

    PMID: 17011402BACKGROUND
  • Demissie K, Marcella SW, Breckenridge MB, Rhoads GG. Maternal asthma and transient tachypnea of the newborn. Pediatrics. 1998 Jul;102(1 Pt 1):84-90. doi: 10.1542/peds.102.1.84.

    PMID: 9651418BACKGROUND
  • Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care. 1998 Aug;21 Suppl 2:B79-84.

    PMID: 9704232BACKGROUND
  • Tutdibi E, Hospes B, Landmann E, Gortner L, Satar M, Yurdakok M, Dellagrammaticas H, Ors R, Ilikkan B, Ovali F, Sarman G, Kumral A, Arslanoglu S, Koc H, Yildiran A. Transient tachypnea of the newborn (TTN): a role for polymorphisms of surfactant protein B (SP-B) encoding gene? Klin Padiatr. 2003 Sep-Oct;215(5):248-52. doi: 10.1055/s-2003-42670.

    PMID: 14520584BACKGROUND
  • Adams JM, Moreno J, Reynolds K, Campbell DW IV, Smith EO, Weisman LE. Resource utilization among neonatologists in a university children's hospital. Pediatrics. 1997 Jun;99(6):E2. doi: 10.1542/peds.99.6.e2.

    PMID: 9164798BACKGROUND
  • Lewis V, Whitelaw A. Furosemide for transient tachypnea of the newborn. Cochrane Database Syst Rev. 2002;(1):CD003064. doi: 10.1002/14651858.CD003064.

    PMID: 11869651BACKGROUND
  • Neville MC, Morton J. Physiology and endocrine changes underlying human lactogenesis II. J Nutr. 2001 Nov;131(11):3005S-8S. doi: 10.1093/jn/131.11.3005S.

    PMID: 11694636BACKGROUND
  • Stroustrup A, Trasande L, Holzman IR. Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn. J Pediatr. 2012 Jan;160(1):38-43.e1. doi: 10.1016/j.jpeds.2011.06.027. Epub 2011 Aug 11.

MeSH Terms

Conditions

Transient Tachypnea of the NewbornPremature Birth

Condition Hierarchy (Ancestors)

Respiratory Distress Syndrome, NewbornRespiratory Distress SyndromeLung DiseasesRespiratory Tract DiseasesRespiration DisordersTachypneaInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Limitations and Caveats

As a small, single center study, our results may not be fully generalizable to the TTN patient population in all hospital types on a national level.

Results Point of Contact

Title
Dr. Annemarie Stroustrup
Organization
Icahn School of Medicine at Mount Sinai

Study Officials

  • Annemarie Stroustrup, MD, MPH

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2010

First Posted

October 20, 2010

Study Start

June 1, 2008

Primary Completion

September 1, 2010

Study Completion

September 1, 2010

Last Updated

November 28, 2013

Results First Posted

November 28, 2013

Record last verified: 2013-09

Locations